Ultragenyx Stock Price Prediction

RARE Stock  USD 48.13  0.77  1.63%   
The RSI of Ultragenyx's share price is below 30 at the present time indicating that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Ultragenyx, making its price go up or down.

Oversold Vs Overbought

29

 
Oversold
 
Overbought
The successful prediction of Ultragenyx's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Ultragenyx and does not consider all of the tangible or intangible factors available from Ultragenyx's fundamental data. We analyze noise-free headlines and recent hype associated with Ultragenyx, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Ultragenyx's stock price prediction:
EPS Estimate Next Quarter
(1.36)
EPS Estimate Current Year
(6.22)
EPS Estimate Next Year
(5.11)
Wall Street Target Price
92.4286
EPS Estimate Current Quarter
(1.45)
Using Ultragenyx hype-based prediction, you can estimate the value of Ultragenyx from the perspective of Ultragenyx response to recently generated media hype and the effects of current headlines on its competitors.

Ultragenyx Hype to Price Pattern

Investor biases related to Ultragenyx's public news can be used to forecast risks associated with an investment in Ultragenyx. The trend in average sentiment can be used to explain how an investor holding Ultragenyx can time the market purely based on public headlines and social activities around Ultragenyx. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Ultragenyx's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Ultragenyx.
The fear of missing out, i.e., FOMO, can cause potential investors in Ultragenyx to buy its stock at a price that has no basis in reality. In that case, they are not buying Ultragenyx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Ultragenyx after-hype prediction price

    
  USD 48.11  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Ultragenyx Basic Forecasting Models to cross-verify your projections.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.
Intrinsic
Valuation
LowRealHigh
43.3259.1761.11
Details
Naive
Forecast
LowNextHigh
49.4151.3553.29
Details
21 Analysts
Consensus
LowTargetHigh
82.4190.56100.52
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.61-1.56-1.51
Details

Ultragenyx After-Hype Price Prediction Density Analysis

As far as predicting the price of Ultragenyx at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ultragenyx or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ultragenyx, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Ultragenyx Estimiated After-Hype Price Volatility

In the context of predicting Ultragenyx's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ultragenyx's historical news coverage. Ultragenyx's after-hype downside and upside margins for the prediction period are 46.17 and 50.05, respectively. We have considered Ultragenyx's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
48.13
48.11
After-hype Price
50.05
Upside
Ultragenyx is very steady at this time. Analysis and calculation of next after-hype price of Ultragenyx is based on 3 months time horizon.

Ultragenyx Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Ultragenyx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ultragenyx backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ultragenyx, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.21 
1.94
  0.02 
  0.01 
10 Events / Month
13 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
48.13
48.11
0.04 
1,940  
Notes

Ultragenyx Hype Timeline

Ultragenyx is at this time traded for 48.13. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.01. Ultragenyx is projected to decline in value after the next headline, with the price expected to drop to 48.11. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.04%, whereas the daily expected return is at this time at -0.21%. The volatility of related hype on Ultragenyx is about 3104.0%, with the expected price after the next announcement by competition of 48.14. About 98.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 6.35. Ultragenyx had not issued any dividends in recent years. The entity had 1:3 split on the 17th of January 2014. Given the investment horizon of 90 days the next projected press release will be in about 10 days.
Check out Ultragenyx Basic Forecasting Models to cross-verify your projections.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.

Ultragenyx Related Hype Analysis

Having access to credible news sources related to Ultragenyx's direct competition is more important than ever and may enhance your ability to predict Ultragenyx's future price movements. Getting to know how Ultragenyx's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ultragenyx may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
XFORX4 Pharmaceuticals 0.02 8 per month 0.00 (0.04) 8.82 (10.61) 62.35 
TERNTerns Pharmaceuticals 0.03 11 per month 0.00 (0.07) 6.02 (5.96) 34.09 
DAWNDay One Biopharmaceuticals 0.27 10 per month 0.00 (0.05) 3.84 (3.69) 11.44 
PDSBPDS Biotechnology Corp 0.10 10 per month 0.00 (0.12) 7.67 (6.76) 31.83 
INZYInozyme Pharma(0.32)6 per month 0.00 (0.31) 5.07 (7.92) 16.62 
MRTXMirati Ther(1.10)37 per month 0.00 (0.18) 4.02 (4.07) 16.13 
AMLXAmylyx Pharmaceuticals 0.14 9 per month 4.07  0.27  10.06 (6.13) 33.56 
APLSApellis Pharmaceuticals(1.10)8 per month 0.00 (0.08) 4.48 (5.17) 15.97 
CRNXCrinetics Pharmaceuticals(1.87)11 per month 2.47 (0) 3.67 (3.45) 16.75 
ARVNArvinas(0.58)9 per month 3.44 (0.02) 4.85 (5.50) 17.13 
RVMDRevolution Medicines(0.55)10 per month 2.02  0.14  4.81 (3.24) 10.95 
KURAKura Oncology(0.57)6 per month 0.00 (0.17) 4.98 (4.04) 42.52 
ABOSAcumen Pharmaceuticals(0.04)8 per month 0.00 (0.07) 7.52 (6.78) 28.07 
INCYIncyte 3.45 10 per month 2.00  0.05  3.02 (2.70) 20.37 
ALNYAlnylam Pharmaceuticals(3.53)9 per month 0.00 (0.10) 2.85 (3.88) 13.26 
UTHRUnited Therapeutics 6.65 10 per month 1.84  0.01  2.89 (3.07) 9.81 

Ultragenyx Additional Predictive Modules

Most predictive techniques to examine Ultragenyx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ultragenyx using various technical indicators. When you analyze Ultragenyx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Ultragenyx Predictive Indicators

The successful prediction of Ultragenyx stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ultragenyx, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ultragenyx based on analysis of Ultragenyx hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ultragenyx's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ultragenyx's related companies.
 2023 2024 (projected)
Dividend Yield0.00310.002755
Price To Sales Ratio8.17.69

Story Coverage note for Ultragenyx

The number of cover stories for Ultragenyx depends on current market conditions and Ultragenyx's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ultragenyx is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ultragenyx's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Ultragenyx Short Properties

Ultragenyx's future price predictability will typically decrease when Ultragenyx's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ultragenyx often depends not only on the future outlook of the potential Ultragenyx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ultragenyx's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding73.5 M
Cash And Short Term Investments577.2 M

Complementary Tools for Ultragenyx Stock analysis

When running Ultragenyx's price analysis, check to measure Ultragenyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultragenyx is operating at the current time. Most of Ultragenyx's value examination focuses on studying past and present price action to predict the probability of Ultragenyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultragenyx's price. Additionally, you may evaluate how the addition of Ultragenyx to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios